The store will not work correctly when cookies are disabled.
1-(biphenyl-4-yl)benzo[cd]indol-2(1H)-one
ID: ALA4083592
PubChem CID: 629397
Max Phase: Preclinical
Molecular Formula: C23H15NO
Molecular Weight: 321.38
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C1c2cccc3cccc(c23)N1c1ccc(-c2ccccc2)cc1
Standard InChI: InChI=1S/C23H15NO/c25-23-20-10-4-8-18-9-5-11-21(22(18)20)24(23)19-14-12-17(13-15-19)16-6-2-1-3-7-16/h1-15H
Standard InChI Key: LBEUOFYUAJUPQX-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 29 0 0 0 0 0 0 0 0999 V2000
38.2786 -14.4246 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.2775 -15.2442 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.9855 -15.6531 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.6931 -15.2400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.4017 -15.6471 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.1099 -15.2363 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.1052 -14.4142 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.9837 -14.0158 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.6918 -14.4201 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.3943 -14.0079 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.0715 -13.2191 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.2693 -13.1844 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.8089 -12.5092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.1654 -11.7768 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.7058 -11.1020 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.8900 -11.1627 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.5359 -11.9039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.9977 -12.5756 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.4286 -10.4890 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.7839 -9.7518 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.3234 -9.0777 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5077 -9.1394 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.1546 -9.8811 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.6172 -10.5522 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.5415 -12.5506 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
8 1 1 0
9 4 1 0
4 5 1 0
5 6 2 0
6 7 1 0
7 10 2 0
10 9 1 0
8 9 2 0
10 11 1 0
11 12 1 0
12 8 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
16 19 1 0
11 25 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 321.38 | Molecular Weight (Monoisotopic): 321.1154 | AlogP: 5.80 | #Rotatable Bonds: 2 |
Polar Surface Area: 20.31 | Molecular Species: NEUTRAL | HBA: 1 | HBD: ┄ |
#RO5 Violations: 1 | HBA (Lipinski): 2 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 5.25 | CX LogD: 5.25 |
Aromatic Rings: 4 | Heavy Atoms: 25 | QED Weighted: 0.46 | Np Likeness Score: -0.73 |
References
1. Jiang Y, Zhuang C, Chen L, Lu J, Dong G, Miao Z, Zhang W, Li J, Sheng C.. (2017) Structural Biology-Inspired Discovery of Novel KRAS-PDEδ Inhibitors., 60 (22): [PMID:28929751] [10.1021/acs.jmedchem.7b01243] |